Clinical Trials in Georgia

Showing 7121-7140 of 19,050 trials

Dragon Ambient eXperience (DAX) Copilot Evaluation

NCT06329427

AI solutions like, Dragon Ambient eXperience (DAX) Copilot (Nuance/Microsoft), hold the potential to significantly enhance provider and patient interactions and alleviate pain points that contribute to burn out. Atrium Health was the first healthcare system in the world to pilot Nuance's DAX Copilot intelligence (AI) enabled scribe software, which synthesizes a draft clinic note by "listening" to the conversation between a provider and patient. After 180 days of use by primary care clinicians and advanced practice providers (APPs), along with a control group, the investigators assess provider satisfaction, patient experience, and provider efficiency through qualitative and quantitative methods.

Automated Clinical Documentation

Wake Forest University Health Sciences238 participantsStarted Jun 2023

Macon, Georgia, United States • Rome, Georgia, United States • Charlotte, North Carolina, United States +2 more locations

COMPLETEDNA65 miles

Multiple Cardiac Sensors for the Management of Heart Failure

NCT03237858

The MANAGE-HF study is a multi-center, global, prospective, open label, multi-phase trial intended to evaluate the clinical efficacy of the HeartLogic heart failure diagnostic feature.

Heart Failure, Congestive

Boston Scientific Corporation200 participantsStarted Aug 2017

Huntsville, Alabama, United States • Jonesboro, Arkansas, United States • Los Angeles, California, United States +27 more locations

Dragon Ambient eXperience (DAX) Copilot Evaluation

Multiple Cardiac Sensors for the Management of Heart Failure

Find Trials by Condition in Georgia

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Evaluation of S-600918 in Adults With Refractory Chronic Cough

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis

Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION

A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients